The global oncology drugs market revenue is estimated to reach USD 202.13 Billion by 2024 expanding at a CAGR of 7.8% from 2019 to 2024.
Axiom
Market Research and Consulting added a, Oncology Drugs Market Report, By Therapeutic Modules, Cancer Type and
Geography – Global Market Share, Trend Analysis and Forecast up to 2024”. The global oncology drugs market
revenue is estimated to reach USD 202.13 Billion by 2024 expanding at a CAGR of
7.8% from 2019 to 2024.
Immunotherapies/ biologics are emerging as potential
therapies to find the permanent cure for various cancer types. Amongst various
biologics, drugs based on monoclonal antibodies (mAbs) have gained significant
attention in recent years due to their high efficacy.
The cancer drugs market is driven by the growing prevalence
of various types of cancer, increasing demand of biological and targeted drug
therapies, continuous patent expiry of key cancer drugs and the rising impact
of biosimilars. However, the high cost of drug development, the threat of
failure and the adverse effects of cancer drug therapy, particularly
chemotherapy, hinders the market growth. Developed nations have implemented
strict regulations for the design and development of cancer drugs.
Oncology Drugs Market Analysis by Cancer Type:
Basis of cancer type, the global oncology drugs market is
segmented into blood cancer, breast cancer, gastrointestinal cancer, prostate
cancer, lung cancer, skin cancer and others.
Oncology Drugs Market Analysis by Therapeutic Modules:
Based on the therapeutic modules, the market is segmented
into chemotherapy, targeted therapy, immunotherapy, hormonal therapy and
others.
Oncology Drugs Market Analysis based Geography:
By geography, the market is fragmented into North America,
Europe, Asia Pacific, Middle East and Africa and Latin America. North America
is anticipated to remain the leading region over the forecast period from 2018
to 2024. Demand for cancer drugs was highest in North America especially in the
U.S.
Leading
Companies of Oncology Drugs Market:
Amgen Inc., Johnson and Johnson, Roche Diagnostics,
GlaxoSmithKline PLC, Merck & Company, Novartis AG, Pfizer, Sanofi, Eli
Lilly and Company, Celgene Corporation, Bayer, Amgen, Merck, Bristol-Myers
Squibb, Ariad Pharmaceuticals, Hoffmann-La Roche Ltd, Boehringer Ingelheim
GmbH, and Teva Pharmaceuticals among others.
About Axiom MRC:
Axiom Market Research &
Consulting™ (also known as Axiom MRC), is a full-service market research and
data analytics firm, driven by a simple aim of providing key market intelligence
to companies to assist them in taking informed business decisions pertaining to
their marketing strategy, investments, new product launches, market
competition, consumer or end users, social media trends etc.
Media Contact:
Ganesh Sai
616 Corporate Way, Suite 2-4268
Valley Cottage, NY, United States
Email: sales@axiommrc.com
Tel: +1(845)875-9786, +44(0) 20
23869707
Comments
Post a Comment